News

Flickr/United States Mission Geneva, Eric Bridiers
GHTC issues statement on ending tuberculosis at WHO Executive Board meeting

GHTC issued a statement at the 144th session of the World Health Organization (WHO) Executive Board urging Member States to realign National TB Strategic Plans, including on research and development, to fulfill the commitments of the High-Level Meeting (HLM) on Tuberculosis. The statement, which was issued in partnership with the Global Health Council, American Academy of Pediatrics, and ACTION, welcomed the HLM's attention to the neglected needs of children, which affects approximately one million children annually.

PDF

Flickr/United State Mission Geneva
GHTC issues statement on equitable access to medicines at WHO Executive Board meeting

GHTC issued a statement at the 144th session of the World Health Organization (WHO) Executive Board supporting the ongoing efforts of WHO to increase equitable access to medicines, vaccines, and other health products. The statement, which was issued in partnership with the Global Health Council, the American Academy of Pediatrics, and NCD Child, encourages WHO to support a comprehensive approach to improving access that considers affordability, acceptability, availability, and quality.

PDF

CDC/James Gathany
GHTC responds to RFI on CARB National Action Plan

GHTC submitted comments to a US Department of Health and Human Services request for information (RFI)on the next National Action Plan for Combatting Antibiotic Resistant Bacteria (CARB) 2020-2025. GHTC’s submission encouraged the prioritization of R&D to combat antimicrobial resistance globally.

PDF

PATH/Patrick McKern
GHTC sends letter of support for National Biodefense Strategy

GHTC sent a letter to Secretary of Health and Human Services Alex Azar in support of the National Biodefense Strategy released by the Administration in September. The letter commends the goals in the strategy aimed at accelerating basic and applied R&D of new antimicrobials, novel therapeutics, vaccines, and diagnostic tests; promoting increased global capacities for R&D, and integrating R&D into federal planning before and during a potential bio-incident.

PDF

All News

Announcements

Breakthroughs Blog

GHTC in the Media

Advocacy Actions

Our members work to improve health worldwide